501
|
|
|
G protein-coupled receptor class C group 5 member D |
- |
|
502
|
|
|
G protein-coupled receptor class C group 6 member A |
GPCR, bA86F4.3 |
|
503
|
|
|
GPRIN family member 3 |
GRIN3 |
|
504
|
|
|
G protein pathway suppressor 1 |
COPS1, CSN1, SGN1 |
|
505
|
|
|
G protein signaling modulator 1 |
AGS3 |
Ankylosing spondylitis, Coronary artery disease, Diabetes mellitus, Diabetic eye disease, Diabetic neuropathy, Diabetic retinopathy, Inflammatory bowel disease, Myocardial infarction, Diabetes mellitus type 2, Diabetic nephropathy type 2, Ulcerative colitis |
506
|
|
|
G protein signaling modulator 2 |
CMCS, DFNB82, LGN, PINS |
|
507
|
|
|
G protein signaling modulator 3 |
AGS4, C6orf9, G18, G18.1a, G18.1b, G18.2, NG1 |
|
508
|
|
|
Glutamic--pyruvic transaminase |
AAT1, ALT, ALT1, GPT1, SGPT |
|
509
|
|
|
Glutamic--pyruvic transaminase 2 |
ALT2, GPT 2, MRT49, NEDSPM |
|
510
|
|
|
Glutathione peroxidase 1 |
GPXD, GSHPX1 |
Anemia, Sickle cell anemia, Attention deficit hyperactivity disorder, Autism, Brain ischemia, Breast neoplasms, Renal cell carcinoma, Squamous cell carcinoma, Transitional cell carcinoma, Dilated cardiomyopathy, Cardiovascular disease, Ischemic heart disease, Coronary artery disease, Major depressive disorder, Diabetes mellitus type 2, Epilepsy, Fatty liver, Fatty liver, alcoholic, Genetic predisposition to disease, Hereditary hemolytic anemia, Head and neck neoplasms, Hyperglycemia, Hyperinsulinism, Hypertension, Hyperthermia, Hyperthyroidism, Kidney failure, Lung neoplasms, Mood disorder, Myocardial ischemia, Obesity, Osteoporosis, Iron deficiency anemia, Urinary bladder neoplasmsView all (19 more) |